concept

DEXAMETHASONE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DEXAMETHASONE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

55Connections

0Hypotheses

0Analyses

50Outgoing

5Incoming

0Experiments

0Debates

No summary available yet. View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DEXAMETHASONE
Key Genes/Proteins	ABCA1, ALPHA-SYNUCLEIN, APP, IL-6, SQSTM1, STING
Related Diseases	CANCER, CHOLESTEROL, DEPRESSION, FIBROSIS, SARCOPENIA

Pathway Diagram

graph TD
    DEXAMETHASONE["DEXAMETHASONE"]
    DEXAMETHASONE -->|"downregulates"| KCNK2["KCNK2"]
    DEXAMETHASONE -->|"causes"| Ocular_Hypertension["Ocular Hypertension"]
    DEXAMETHASONE -->|"upregulates"| FSP1["FSP1"]
    DEXAMETHASONE -->|"causes"| Glucocorticoid_Induced_Ocular_["Glucocorticoid-Induced Ocular Hypertension"]
    DEXAMETHASONE -->|"causes"| Glucocorticoid_Induced_Muscle_["Glucocorticoid-Induced Muscle Atrophy"]
    DEXAMETHASONE -->|"modulates"| Trabecular_Meshwork["Trabecular Meshwork"]
    DEXAMETHASONE -->|"causes"| Trabecular_Meshwork_Cell_Depol["Trabecular Meshwork Cell Depolarization"]
    DEPRESSION["DEPRESSION"] -->|"inhibits"| DEXAMETHASONE

Outgoing (50)

Target	Relation	Type	Str
KCNK2	downregulates	entity	0.95
muscle cell atrophy	causes	phenotype	0.95
Glucocorticoid-Induced Muscle Atrophy	causes	disease	0.90
Ocular Hypertension	causes	disease	0.90
FSP1	upregulates	gene	0.90
Glucocorticoid-Induced Ocular Hypertension	causes	disease	0.90
KCNK2	downregulates	gene	0.90
Trabecular Meshwork	modulates	cell_type	0.85
Trabecular Meshwork Cell Depolarization	causes	process	0.85
TREK-1	inhibits	gene	0.80
Fibrosis	upregulates	process	0.80
EPHA5	downregulates	gene	0.80
Ocular Hypertension	causes	disease	0.80
TREK-1	regulates	entity	0.70
NR3C1	regulates	gene	0.70
CHOLESTEROL	activates	phenotype	0.70
CANCER	activates	disease	0.70
MACROPHAGES	regulates	cell_type	0.70
SQSTM1	interacts_with	gene	0.70
ALPHA-SYNUCLEIN	activates	protein	0.65
ALPHA-SYNUCLEIN	inhibits	protein	0.65
STING	inhibits	gene	0.65
SARCOPENIA	activates	disease	0.65
ABCA1	regulates	gene	0.60
prion disease	treats	disease	0.60
NR3C1	inhibits	gene	0.60
NFE2L2	inhibits	gene	0.60
NFE2L2	regulates	gene	0.60
ABCA1	activates	gene	0.60
CRH	biomarker_for	gene	0.60
Parkinson's disease	treats	disease	0.60
NR3C1	interacts_with	gene	0.60
CRH	inhibits	gene	0.60
spinal muscular atrophy	treats	disease	0.60
depression	treats	disease	0.60
TNF	inhibits	gene	0.60
ABCA1	associated_with	gene	0.50
CHOLESTEROL	associated_with	phenotype	0.50
CANCER	associated_with	disease	0.50
FIBROSIS	associated_with	disease	0.50
OSTEOBLASTS	associated_with	cell_type	0.50
APP	associated_with	gene	0.50
SQSTM1	associated_with	gene	0.50
MACROPHAGES	associated_with	cell_type	0.50
INFLIXIMAB	associated_with	drug	0.45
TNF	associated_with	gene	0.45
DEPRESSION	associated_with	disease	0.45
SARCOPENIA	associated_with	disease	0.45
TNF	inhibits	gene	0.35
IL-6	inhibits	gene	0.35

Incoming (5)

Source	Relation	Type	Str
FIBROSIS	inhibits	disease	0.65
APP	stabilizes	gene	0.60
ALPHA-SYNUCLEIN	associated_with	protein	0.50
DEPRESSION	associated_with	disease	0.45
DEPRESSION	inhibits	disease	0.35

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity